Procaps Group

About Us

Procaps Group, S.A. ("Procaps Group") (NASDAQ: PROC) is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 4,900 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over the counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions.

Press Realease

Procaps Group to Acquire Grupo Somar (including Química y Farmacia, Gelcaps and related entities) from Advent International, gaining an important presence in Mexico, the Region´s Second Largest Market
May 17, 2022 3:56pm EDT

Read more - English Read more - Spanish Read more - Portuguese

Pharmaceutical Group
dedicated to delivering
health and nutrition

We employ over 4,900 people across 13 countries
in Latin America.

Our products reach 
50+ markets

Virtual Tour